Michael Addition
FULL PAPER
(c=0.34 in CHCl3); 91% ee (determined by HPLC analysis: Daicel chir-
(R)-Ethyl 2-cyano-2-methyl-5-oxo-5-(thiophen-2-yl)pentanoate (4y): Col-
alcel OJ, hexane/iPrOH 90:10, 1.0 mLminÀ1
,
l=220 nm,
t
C
orless oil; Yield: 91%; Rf =0.1 (petroleum ether/EtOAc 25:1); [a]D20
=
+5.0 (c=0.48 in CHCl3); 96% ee (determined by HPLC analysis: Daicel
chiralcel OJ, hexane/iPrOH 90:10, 1.0 mLminÀ1, l=254 nm, t
(major)=
25.01 min, t
(minor)=27.52 min); 1H NMR (300 MHz, CDCl3): d=7.79
20.25 min, t
ACHTREUNG
ACHTREUNG
7.96 (m, 2H), 7.59 (t, J=7.2Hz, 1H), 7.48 (t, J=7.2 Hz, 2H), 4.32–4.24
(m, 2H), 3.29–3.11 (m, 2H), 2.49–2.41 (m, 1H), 2.28–2.21 (m, 1H), 1.68
(s, 3H), 1.33 ppm (t, J=7.2Hz, 3H); 13C NMR (75 MHz, CDCl3): d=
197.4, 168.9, 136.2, 133.5, 128.7, 128.0, 119.7, 63.0, 43.3, 34.4, 32.1, 23.7,
14.0 ppm; IR (film): n˜ =2244, 1738, 1684 cmÀ1; ESI-HRMS: m/z: calcd
for C15H17NO3 +Na: 282.1101; found: 282.1103.
AHCTREUNG
(dd, J=1.1, 3.8 Hz, 1H), 7.70 (dd, J=1.1, 4.9 Hz, 1H), 7.19–7.16 (m,
1H), 4.34–4.27 (m, 2H), 3.26–3.06 (m, 2H), 2.52–2.42 (m, 1H), 2.31–2.21
(m, 1H), 1.70 (s, 3H), 1.35 ppm (t, J=7.1 Hz, 3H); 13C NMR (75 MHz,
CDCl3): d=190.3, 168.8, 143.4, 134.1, 132.2, 128.2, 119.6, 63.0, 43.3, 35.0,
32.2, 23.6, 13.9 ppm; IR (film): n˜ =2244, 1737, 1672 cmÀ1; ESI-HRMS: m/
z: calcd for C13H15NO3S+Na: 288.0665; found: 288.0663.
(R)-Ethyl 2-cyano-2-(3-oxo-3-phenylpropyl)hexanoate (4t): Colorless oil;
Yield 72%; Rf =0.1 (petroleum ether/EtOAc 55:1); [a]2D0 =+3.1 (c=0.26
in CHCl3); 92% ee (determined by HPLC analysis: Daicel chiralcel AS,
(S)-Ethyl 2-benzyl-2-cyano-5-oxo-5-(thiophen-2-yl)pentanoate (4z): Col-
orless oil; Yield 98%; Rf =0.1 (petroleum ether/EtOAc 25:1); [a]D20
=
hexane/iPrOH 90:10, 1.0 mLminÀ1
, l=220 nm, t (major)=6.78 min,
1
+16.3 (c=0.63 in CHCl3); 97% ee (determined by HPLC analysis:
t (minor)=7.47 min); H NMR (300 MHz, CDCl3): d=7.96 (d, J=7.2Hz,
2H), 7.59 (t, J=7.1 Hz, 1H), 7.48 (t, J=7.2Hz, 2H), 4.29 (q, J=7.1 Hz,
2H), 3.33–3.22 (m, 1H), 3.11–3.00 (m, 1H), 2.46–2.36 (m, 1H), 2.30–2.20
(m, 1H), 2.05–1.95 (m, 1H), 1.90–1.80 (m, 1H), 1.41–1.25 (m, 7H),
0.93 ppm (t, J=7.2Hz, 3H); 13C NMR (75 MHz, CDCl3): d=197.5,
168.7, 136.2, 133.4, 128.7, 128.0, 119.1, 62.8, 49.1, 37.3, 34.4, 31.3, 27.5,
22.4, 14.1, 13.7 ppm; IR (film): n˜ =2244, 1740, 1688 cmÀ1; ESI-HRMS: m/
z: calcd for C18H23NO3 +Na: 324.1570; found: 324.1564.
Daicel chiralcel OD, hexane/iPrOH 90:10, 1.0 mLminÀ1, l=254 nm, t-
A
N
d=7.77 (dd, J=1.1, 3.8 Hz, 1H), 7.69 (dd, J=1.1, 5.0 Hz, 1H), 7.40–7.32
(m, 5H), 7.18–7.15 (m, 1H), 4.20 (q, J=7.2Hz, 2H), 3.33–3.14 (m, 3H),
3.10–2.99 (m, 1H), 2.61–2.51 (m, 1H), 2.37–2.27 (m, 1H), 1.21 ppm (t,
J=7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3): d=190.1, 168.0, 143.4,
134.1, 133.8, 132.2, 129.9, 128.6, 128.2, 127.9, 118.5, 62.9, 50.7, 43.2, 35.0,
31.3, 13.8 ppm; IR (film): n˜ =2248, 1735, 1671 cmÀ1; ESI-HRMS: m/z:
calcd for C19H19NO3S+Na: 364.0978; found: 364.0974.
(S)-Ethyl 2-benzyl-2-cyano-5-oxo-5-phenylpentanoate (4u): Colorless oil;
Yield: 90%; Rf =0.1 (petroleum ether/EtOAc 35:1); [a]2D0 =+18.0 (c=
0.50 in CHCl3); 92% ee (determined by HPLC analysis: Daicel chiralcel
Synthesis of optically active b2,2-amino acid esters 5, 6, and 7
AS, hexane/iPrOH 90:10, 1.0 mLminÀ1, l=220 nm, t
ACHTREUNG
Compound 5: Ethylene glycol (59.8 mg, 0.96 mmol) was added to a solu-
tion of 4d (134.0 mg, 0.48 mmol, 92% ee) and pTsOH (18.3 mg,
0.096 mmol) in benzene (10 mL). The mixture was heated to reflux for
6 h. After concentration, the residue was subjected to flash chromatogra-
phy (elution gradient: petroleum ether/EtOAc 25:1) to give the ketal in-
termediate. (Boc)2O (116.0 mg, 0.53 mmol) and Raney-Ni (28.5 mg) were
added to a solution of above compound in ethanol (3.0 mL). The mixture
was stirred under H2 (50 psi) at room temperature for 12h. Then the mix-
ture was filtered through celite, washed with EtOAc (20 mL) and the re-
sulting filtrate was concentrated in vacuum. The residue was subjected to
t
ACHTREUNG
2H), 7.61–7.56 (m, 1H), 7.50–7.45 (m, 1H), 7.36–7.30 (m, 5H), 4.17 (q,
J=7.1 Hz, 2H), 3.35–3.24 (m, 2H), 3.17–3.01 (m, 2H), 2.58–2.48 (m,
1H), 2.36–2.26 (m, 1H), 1.17 ppm (t, J=7.1 Hz, 3H); 13C NMR (75 MHz,
CDCl3): d=197.3, 168.1, 136.2, 133.8, 133.5, 129.9, 128.7, 128.6, 128.0,
118.7, 62.9, 50.7, 43.3, 34.4, 31.3, 13.9 ppm; IR (film): n˜ =2245, 1740,
1687 cmÀ1; ESI-HRMS: m/z: calcd for C21H21NO3 +Na: 358.1414; found:
358.1401.
(S)-Ethyl 2-cyano-2-isopropyl-5-oxo-5-phenylpentanoate (4v): Colorless
oil; Yield: 66%; Rf =0.1 (petroleum ether/EtOAc 45:1); [a]2D0 =+15.8
(c=0.32in CHCl 3); 93% ee (determined by HPLC analysis: Daicel chir-
flash chromatography to give the Boc-protected
b 5
2,2-amino ester
(168.8 mg, 83% yield for two steps). Rf =0.15 (petroleum ether/EtOAc
10:1); [a]2D0 =+21.7 (c=0.78 in CHCl3); 92% ee (determined by HPLC
analysis: Daicel chiralcel AD, hexane/iPrOH 90:10, 1.0 mLminÀ1, l=
alcel AS, hexane/iPrOH 90:10, 1.0 mLminÀ1
6.90 min, t
,
l=254 nm,
t(major)=
A
ACHTREUNG
254 nm, t
N
N
7.93 (m, 2H), 7.61–7.56 (m, 1H), 7.50–7.45 (m, 2H), 4.30 (q, J=7.1 Hz,
2H), 3.27–3.22 (m, 1H), 2.99–2.92 (m, 1H), 2.35–2.24 (m, 3H), 1.34 (t,
J=7.1 Hz, 3H), 1.17 (d, J=6.8 Hz, 3H), 1.08 ppm (d, J=6.7 Hz, 3H);
13C NMR (75 MHz, CDCl3): d=197.6, 168.8, 136.2, 133.4, 128.7, 128.0,
118.0, 62.7, 54.9, 35.2, 34.7, 29.1, 19.0, 17.7, 14.1 ppm; IR (film): n˜ =2242,
1739, 1688 cmÀ1; ESI-HRMS: m/z: calcd for C17H21NO3 +Na: 310.1414;
found: 310.1411.
CDCl3): d=7.25–7.22 (m. 2H), 7.06–7.00 (m, 2H), 4.78 (t, J=5.6 Hz,
1H), 4.25–4.17 (m, 2H), 3.97–3.89 (m, 4H), 3.78–3.73 (m, 1H), 3.61–3.56
(m, 1H), 2.13–2.07 (m, 2H), 1.71–1.65 (m, 1H), 1.57–1.51 (m, 1H), 1.37
(s, 9H), 1.32(s, 3H), 1.25 ppm (t, J=7.2Hz, 3H); 13C NMR (75 MHz,
CDCl3): d=174.5, 161.7 (d, 1J
(C,F)=7.7 Hz), 115.2(d, 2J
45.4, 33.4, 25.7, 28.2, 23.7, 14.0 ppm; IR (KBr): n˜ =3460, 3388, 1722 cmÀ1
ACHTREUNG
A
ACHTREUNG
;
(R)-Ethyl 5-(4’-bromophenyl)-2-cyano-2-methyl-5-oxopentanoate (4w):
ESI-HRMS: m/z: calcd for C22H32FNO6 +Na: 448.2106; found: 448.2105.
Colorless oil; Yield: 67%; Rf =0.1 (petroleum ether/EtOAc 50:1); [a]D20
=
Compound 6: Compound 6 was prepared by a similar hydrogenation pro-
cedure to the above (31.6 mg, 91% yield); Rf =0.10 (petroleum ether/
EtOAc 50:1); [a]2D0 =+78.4 (c=0.56 in CHCl3); 91% ee (determined by
+2.8 (c=0.35 in CHCl3); 85% ee (determined by HPLC analysis: Daicel
chiralcel AD, hexane/iPrOH 90:10, 1.0 mLminÀ1, l=254 nm, t
(minor)=
9.29 min, t
(major)=9.91 min); 1H NMR (300 MHz, CDCl3): d=7.87–7.83
AHCTREUNG
HPLC analysis: Daicel chiralcel AD, hexane/iPrOH 95:5, 1.0 mLminÀ1
,
ACHTREUNG
l=254 nm,
t
A
t
N
1H NMR
(m, 2H), 7.67–7.62 (m, 2H), 4.34–4.27 (m, 2H), 3.28–3.07 (m, 2H), 2.51–
2.41 (m, 1H), 2.30–2.20 (m, 1H), 1.70 (s, 3H), 1.35 ppm (t, J=7.1 Hz,
3H); 13C NMR (75 MHz, CDCl3): d=196.4, 168.8, 135.0, 132.0, 129.5,
128.7, 119.6, 63.0, 43.2, 34.4, 31.9, 23.7, 14.0 ppm; IR (film): n˜ =2251,
(400 MHz, CDCl3): d=7.48 (d, J=7.6 Hz, 2H), 7.31 (t, J=7.6 Hz, 2H),
7.22 (t, J=7.2Hz, 1H), 4.89 (d, J=14.0 Hz, 1H), 4.30–4.20 (m, 1H),
4.09–3.97 (m, 2H), 3.17 (d, J=14.4 Hz, 1H), 2.49–2.43 (m, 1H), 2.14 (td,
J=5.6, 14.2Hz, 1H), 1.59–1.46 (m, 10H), 1.34–1.30 (m, 1H), 1.18–
1.11 ppm (m, 6H); 13C NMR (75 MHz, CDCl3): d=174.1, 154.6, 138.2,
128.3, 127.4, 126.8, 79.7, 60.9, 49.5, 45.2, 42.2, 28.4, 27.1, 25.2, 15.6,
13.9 ppm; IR (KBr): n˜ =1729, 1691 cmÀ1; ESI-HRMS: m/z: calcd for
C20H29NO4 +Na: 370.1989; found: 370.2004.
1726, 1690 cmÀ1
;
ESI-HRMS: m/z: calcd for C15H16BrNO3 +Na:
360.0206; found: 360.0196.
(R)-Ethyl 2-cyano-5-(4’-methoxyphenyl)-2-methyl-5-oxopentanoate (4x):
Colorless oil; Yield 61%; Rf =0.1 (petroleum ether/EtOAc 25:1); [a]D20
=
+3.3 (c=0.29 in CHCl3); 85% ee (determined by HPLC analysis: Daicel
chiralcel AD, hexane/iPrOH 90:10, 1.0 mLminÀ1, l=254 nm, t
(minor)=
13.52min,
(major)=14.34 min); 1H NMR (300 MHz, CDCl3): d=7.97
AHCTREUNG
Compound 7: Compound 7 was prepared by a similar hydrogenation pro-
cedure to above (103.0 mg, 93% yield); Rf =0.15 (petroleum ether/
EtOAc 50:1); [a]2D0 =+87.7 (c=0.31 in CHCl3); 96% ee (determined by
t
ACHTREUNG
(d, J=6.9 Hz, 2H), 6.97 (d, J=7.0 Hz, 2H), 4.30 (q, J=7.1 Hz, 2H), 3.90
(s, 3H), 3.27–3.05 (m, 2H), 2.50–2.40 (m, 1H), 2.30–2.20 (m, 1H), 1.70 (s,
3H), 1.35 ppm (t, J=7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3): d=195.9,
168.9, 163.7, 130.3, 129.3, 119.7, 113.8, 62.9, 55.5, 43.3, 34.0, 32.3, 23.6,
13.9 cmÀ1; IR (film): n˜ =2245, 1732, 1683 cmÀ1; ESI-HRMS: m/z: calcd
for C16H19NO4 +Na: 312.1206; found: 312.1197.
HPLC analysis: Daicel chiralcel AS, hexane/iPrOH 90:10, 1.0 mLminÀ1
,
l=254 nm,
t
A
t
N
1H NMR
(300 MHz, CDCl3): d=7.59 (t, J=8.0 Hz, 1H), 7.38–7.31 (m, 2H), 7.30–
7.21 (m, 4H), 7.17–7.12 (m, 1H), 7.06–6.99 (m, 1H), 5.31 (brs, 1H), 4.80
(d, J=13.7 Hz, 1H), 4.06 (q, J=7.1 Hz, 2H), 3.30 (d, J=14.2Hz, 1H),
Chem. Eur. J. 2007, 13, 319 – 327
ꢀ 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
325